Search for: "In Re US Bioscience Securities Litigation" Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2021, 2:23 pm by Kevin LaCroix
2020 was an eventful year in the world of corporate and securities litigation. [read post]
23 Apr 2018, 1:20 am by Kevin LaCroix
In addition to increasing the burdens of securities litigation defense, bifurcation deprives defendants of the protections set out under the Private Securities Litigation Reform Act of 1995 (“Reform Act”). [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  Finally, we describe and analyze the real driving forces behind these decisions, and we explain how biotech companies, their attorneys, and insurers can use these insights to greatest advantage. [read post]
25 Jun 2009, 4:29 am
Feb. 19, 2009); In re Nuvelo, Inc., Securities Litigation, 2008 WL 5114325, at *2 (N.D. [read post]
14 May 2020, 2:55 pm by Kevin LaCroix
In at least some instances, the agency’s actions may result in follow-on private securities litigation as well. [read post]
12 Jul 2020, 2:28 pm by Kevin LaCroix
  Pulse Biosciences, on the other hand, took a new route: Per their disclosure, their chairman has agreed to deposit $30 million in cash or marketable securities so that these funds can be used on terms that are similar to the company’s expired D&O insurance program. [read post]
22 May 2014, 5:00 am
Supp. 770, 786 (D.D.C. 1993); In re Vioxx Products Liability Litigation, 235 F.R.D. 334, 344 (E.D. [read post]
27 Sep 2008, 12:08 am
(Biotech Blog) United States: Patent for generating oxygen in a process that mimics photosynthesis (Competitive info)   Products Adderall (Dextroamphetamine/Racemic DL-ampthetamine) - US: Judge denies Sandoz’ bid for summary judgment of non infringement in patent dispute with Shir eover Adderall (Law360) Carbatrol (Carbamazepine) - US: Judge refuses to grant summary judgment to Corepharma in patent dispute with Shire Laboratories over generic Carbatrol… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2008, 1:50 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
23 Aug 2008, 1:23 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
28 Apr 2008, 11:00 am
: (Spicy IP), US: Who’s to blame for rising drug prices? [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit… [read post]
21 Jun 2020, 4:10 pm by INFORRM
Using Data and Respecting Users,, Communications of the ACM, 2020, Marshall W. [read post]
15 Feb 2008, 9:00 am
: (IPBiz),Eco-patent commons meets open innovation: (Securing Innovation),Settle the patent infringement case by selling your company? [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
RE 39,947 owned by Johnson Research & Development Co., Inc. and entitled TOY WATER GUN. [read post]
2 May 2008, 7:00 am
: (Afro-IP), UN agency to address link between IP assets and financial securities: (Intellectual Property Watch), ‘Free’ culture: it’s not what ‘we in the west’ might imagine: (IPcentral.info), What’s your intellectual property strategy? [read post]
The FTC is continuing to use Section 13(b) of the Act to attempt to obtain preliminary and permanent injunctive relief. [read post]